What is miliary tuberculosis?

What is Miliary Tuberculosis?

Miliary tuberculosis is a potentially fatal form of disseminated tuberculosis resulting from massive lymphohematogenous (bloodstream) spread of Mycobacterium tuberculosis bacilli throughout the body, characterized by tiny tuberculous lesions (resembling millet seeds) visible in the lungs and other organs 1, 2.

Epidemiology and Risk Factors

Miliary TB accounts for approximately 1-2% of all TB cases in immunocompetent adults but carries a mortality rate exceeding 30% 1. The condition is uniformly fatal if untreated 3. Key risk factors include:

• HIV/AIDS co-infection (most significant risk factor)
• Anti-TNF-α biological agents and other immunosuppressive medications
• Chronic malnutrition
• Extremes of age (infants and elderly)

The HIV/AIDS pandemic and widespread use of immunosuppressive drugs have fundamentally altered the epidemiology, transforming miliary TB from predominantly a pediatric disease in the pre-antibiotic era to an increasingly common adult condition 4, 2.

Clinical Presentation

The clinical manifestations are notoriously nonspecific, which frequently delays diagnosis:

• Constitutional symptoms: Fever, night sweats, weight loss, fatigue (present in majority)
• Respiratory symptoms: Cough (may be productive or dry), dyspnea
• Extrapulmonary involvement: Occurs in over 60% of patients 1
  • CNS involvement: 10-30% (tuberculous meningitis)
  • Abdominal involvement: 15-30%
  • Skeletal involvement: up to 17%

Critical diagnostic clue: Choroid tubercles on funduscopic examination are pathognomonic for miliary TB and should be actively sought in suspected cases 4, 3.

Laboratory and Imaging Findings

Laboratory abnormalities are common but nonspecific:

• Elevated ESR (nearly universal)
• Anemia and lymphopenia
• Nearly universal CRP elevation
• Hyponatremia (may indicate CNS involvement)

Imaging characteristics:

• Chest X-ray: Classic miliary pattern (1-3mm nodules diffusely distributed), though may be normal early in disease course 5
• High-resolution CT: More sensitive, shows randomly distributed miliary nodules throughout both lungs 6
• Important caveat: Initial imaging may be completely normal, with miliary infiltrates appearing only on repeated imaging after days to weeks 5

Diagnostic Approach

Diagnosis remains challenging due to paucibacillary lesions (low bacterial burden). A systematic approach includes:

1. Multiple specimen collection:

   • Sputum or bronchoalveolar lavage (BAL)
   • Blood cultures (positive in disseminated disease)
   • Bone marrow aspiration and biopsy
   • Liver biopsy (high diagnostic yield)
   • CSF analysis if CNS symptoms present
   • Body fluid analysis (pleural, pericardial, peritoneal)

2. Molecular diagnostics: GeneXpert MTB/RIF and line probe assay significantly improve diagnostic efficiency 1, 4

3. Histopathological examination: Tissue biopsy showing caseating granulomas

4. Novel approaches: Nasopharyngeal swabs have shown promise as non-invasive specimens for molecular testing in pediatric cases 7

Treatment

Standard Pulmonary Miliary TB

A standard 6-month regimen is adequate for isolated pulmonary miliary tuberculosis without CNS involvement 8, 9, 10:

• 2 months: Isoniazid + Rifampin + Pyrazinamide + Ethambutol (HRZE)
• 4 months: Isoniazid + Rifampin (HR)

CNS Involvement

When CNS involvement is present (meningitis, tuberculomas), treatment must be extended to 9-12 months with adjunctive corticosteroids 8, 1:

• Initial phase: 2 months of HRZE
• Continuation phase: 7-10 months of HR
• Adjunctive dexamethasone: Tapered over 6-8 weeks 8

Critical point: All miliary TB cases require lumbar puncture to exclude CNS involvement, as this fundamentally changes treatment duration 9.

Drug-Resistant Miliary TB

For MDR-TB (resistant to isoniazid and rifampin), individualized regimens lasting 18-24 months are required, using drugs with high blood-brain barrier penetration when CNS involvement exists 1. Expert consultation is mandatory 11, 12.

Special Populations

Pregnant women: Use rifampin-based regimens; pyrazinamide is now recommended despite historical concerns, as benefits outweigh theoretical risks. Avoid aminoglycosides (cause congenital deafness) 13.

HIV co-infected patients: Require careful monitoring for drug-drug interactions with antiretrovirals and TB-IRIS (immune reconstitution inflammatory syndrome). TNF-α antagonists may serve as salvage therapy for steroid-refractory TB-IRIS 1.

Children: Same regimens as adults with weight-based dosing. Ethambutol at 15 mg/kg can be used even in young children when drug resistance is suspected 8, 13.

Complications and Monitoring

Life-threatening complications include:

• Acute respiratory distress syndrome (ARDS): High mortality
• Tuberculous meningitis: Requires urgent treatment
• Drug-induced liver injury: Common with first-line agents
• Multi-organ dysfunction

BCG vaccination provides approximately 77% protection against miliary TB in children, making it a cost-effective preventive measure 1.

The key to reducing mortality in miliary TB is maintaining a low threshold for suspicion, particularly in patients with persistent fever and risk factors, even when initial imaging and microbiological tests are negative. Early empiric treatment can be lifesaving while awaiting confirmatory diagnostics 1, 3.